
Innovation
Licensing Agreement with Harmonic Discovery and UCSF for FLT3 Mutated AML Development Program
BioVentures has announced a licensing agreement with Harmonic Discovery and UC San Francisco for the development of a new drug

BioVentures has announced a licensing agreement with Harmonic Discovery and UC San Francisco for the development of a new drug

The BioVentures Development Award Program is a new funding mechanism designed to accelerate the pace of the development of highly innovative technologies and entrepreneurship activity at the University of Arkansas for Medical Sciences (UAMS).